The core activity of a2a pharma is providing consulting services to companies in the pharmaceutical industry. The services include, among others, strategic consulting, market entry support, competitive analysis, and business development. The company supports its customers in accessing regulated markets and helps them find suitable products, brands, or business partners.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Drug discovery and development for oncological diseases, drug-resistant bacterial infections and other life-threatening conditions; computer-aided drug design platform SCULPT with AI-supported molecule development.
Oncology drug programs
Oncology drug programs with MLL-Menin, TACC3, YAP-TEAD and KRAS inhibitors or degraders for leukaemias, solid tumours and hard-to-treat cancers.
Development of anti-infectives
Development of active substances against drug-resistant bacterial infections with targets directed at Gram-negative bacteria and novel candidates that bypass resistance.
Development of therapies for autoimmune diseases
Development of a selective TYK2 pseudokinase inhibitor for autoimmune diseases, focusing on lower toxicity and properties suitable for chronic treatment.
Knowledge
No knowledge articles yet
Once A2A Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.